Graftless Lateral Maxillary Sinus Lift Balloon by Different Antrostomy Sizes With Simultaneous Implant Placement
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03633968 |
|
Recruitment Status : Unknown
Verified August 2018 by ahmed mohammed khalil aldahouk, Cairo University.
Recruitment status was: Recruiting
First Posted : August 16, 2018
Last Update Posted : August 20, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Atrophy of Edentulous Maxillary Alveolar Ridge | Procedure: maxillary sinus lift | Not Applicable |
control group undergoes for graftless sinus lift using AMBE through large antrostomy with simultaneous implant placement. While, study group undergo for graftless sinus lift using AMBE through small antrostomy with simultaneous implant placement. the aim of the study is assessment the effect of antrostomy size on bone formation in graftless sinus lift with simultaneous implant placement.
CBCT will be done before and after the surgery and after 6 months to assess of amount bone gain in mm.
implant stability after 6 months will be determined by using Osstell. Primary outcome: amount of bone gain which will be measured by using linear measurement from CBCT.
secondary outcome: stability of implant by using osstell
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 14 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | assessment of the effect of the antrostomy size in graftless lateral maxillary sinus floor elevation using AMBE (antral membrane balloon elevation) with simultaneous implant placement |
| Masking: | Single (Participant) |
| Masking Description: | assessment of the effect of the antrostomy size in graftless lateral maxillary sinus floor elevation using AMBE (antral membrane balloon elevation) with simultaneous implant placement |
| Primary Purpose: | Health Services Research |
| Official Title: | Assessment of the Effect of the Antrostomy Size in Graftless Lateral Maxillary Sinus Floor Elevation Using AMBE (Antral Membrane Balloon Elevation) With Simultaneous Implant Placement |
| Actual Study Start Date : | July 1, 2018 |
| Estimated Primary Completion Date : | May 2019 |
| Estimated Study Completion Date : | June 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: maxillary sinus lift small antrostomy
local anaesthesia will be given flap will be reflected to expose sinus lateral wall. round diamond bur will be used to make small antrostomy and expose schneiderian membrane. maxillary sinus lift by using antral membrane balloon elevation without using graft material with simultaneous implant placement |
Procedure: maxillary sinus lift
maxillary sinus floor elevation by using balloon through either small or large antrostomy without using graft material with simultaneous implant placement
Other Name: implant placement |
|
Active Comparator: maxillary sinus lift large antrostomy
local anaesthesia will be given flap will be reflected to expose sinus lateral wall round diamond bur will be used to make large antrostomy and expose schneiderian membrane. maxillary sinus lift by using antral membrane balloon elevation without using graft material with simultaneous implant placement |
Procedure: maxillary sinus lift
maxillary sinus floor elevation by using balloon through either small or large antrostomy without using graft material with simultaneous implant placement
Other Name: implant placement |
- amount of bone formation [ Time Frame: after 6 months ]measurement of amount of bone gained by using CBCT
- implant stability [ Time Frame: after 6 months ]measurement of implant stability by using osstell
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients with atrophic maxilla and pneumatization of maxillary sinus with residual bone height from 3-6mm.
- Both sexes
- No intraoral soft and hard tissue pathology,
- No systemic condition that contraindicate implant placement
Exclusion Criteria:
- Sinus pathology.
- Heavy smokers more than 20 cigarettes per day.
- Patients with systemic disease that may affect normal healing.
- Psychiatric problems.
- Disorders to implant are related to history of radiation therapy to head and neck neoplasia or bone augmentation to implant site
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03633968
| Contact: Ahmed a dahouk, BSD | 00201011862613 ext 00201289847733 | a7madmo97@gmail.com | |
| Contact: Ahmed a dr khleel, BSD | 0223642705 | ethics@dentistry.cu.edu.eg |
| Egypt | |
| Faculty of Dentistry, Cairo University | Recruiting |
| Cairo, Al-Manial, Egypt, 11553 | |
| Contact: Ahmed a dahouk, BSD 01289847733 ethics@dentistry.cu.edu.eg | |
| Contact: Ahmed Y dr khaleel 01069617691 ahmed.zayed@dentistry.cu.edu.eg | |
| Principal Investigator: | ahmed a dahouk, bsd | Cairo University |
| Responsible Party: | ahmed mohammed khalil aldahouk, Principal Investigator(doctor), Cairo University |
| ClinicalTrials.gov Identifier: | NCT03633968 |
| Other Study ID Numbers: |
maxillary sinus augmentation |
| First Posted: | August 16, 2018 Key Record Dates |
| Last Update Posted: | August 20, 2018 |
| Last Verified: | August 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | web sites and journals |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
sinus augmentation,lifting |
|
Atrophy Pathological Conditions, Anatomical |

